Tris-2(hydroxyethyl) ammonium 2-methylphenoxyacetate as an inhibitor of synthesis of liver phospholipase A1

Dokl Biochem Biophys. 2011 Sep-Oct:440:219-20. doi: 10.1134/S1607672911050073. Epub 2011 Nov 19.
No abstract available

MeSH terms

  • Animals
  • Atherosclerosis / complications*
  • Atherosclerosis / metabolism
  • Cholesterol / metabolism
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology*
  • Lipoproteins, LDL / metabolism
  • Liver / drug effects
  • Liver / enzymology*
  • Liver Diseases / drug therapy*
  • Liver Diseases / etiology
  • Liver Diseases / metabolism
  • Phenoxyacetates / pharmacology*
  • Phospholipases A1 / antagonists & inhibitors*
  • Phospholipases A1 / drug effects
  • Phospholipases A1 / metabolism*
  • Quaternary Ammonium Compounds / pharmacology*
  • Rabbits
  • Triglycerides / metabolism

Substances

  • Enzyme Inhibitors
  • Lipoproteins, LDL
  • Phenoxyacetates
  • Quaternary Ammonium Compounds
  • Triglycerides
  • trecresanum
  • Cholesterol
  • Phospholipases A1